The Role of Nitric Oxide Synthase Isoforms in Neuropathic Pain Induced by Nerve Injury in Rats.
10.4097/kjae.2005.48.1.76
- Author:
Young Tae JEON
1
;
Kwang Suk SEO
;
Young Jin RO
;
Young Jin LIM
;
Seong Won MIN
;
Yong Chul KIM
;
Chong Soo KIM
;
Sang Chul LEE
;
Seong Deok KIM
Author Information
1. Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
- Publication Type:Original Article
- Keywords:
allodynia;
hyperalgesia;
nitric oxide;
nitric oxide synthase;
neuropathic pain
- MeSH:
Animals;
Central Nervous System Sensitization;
Hyperalgesia;
Hypersensitivity;
Models, Animal;
N-Methylaspartate;
Neuralgia*;
Neurons;
NG-Nitroarginine Methyl Ester;
Nitric Oxide Synthase*;
Nitric Oxide*;
Peripheral Nerve Injuries;
Peripheral Nerves;
Protein Isoforms;
Rats*;
Sciatic Nerve
- From:Korean Journal of Anesthesiology
2005;48(1):76-84
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Peripheral nerve injury may generate pain hypersensitivity, characterized by enhanced nociceptive responses to noxious stimuli and decreased thresholds to innocuous stimuli, and may lead to a chronic neuropathic pain state resulting from an increase in central neuron excitability. This central sensitization is mediated via N-methyl-D-aspartic acid (NMDA) receptor and may involve the production of nitric oxide (NO). In this work, we investigated whether the action of NO and local nitric oxide synthase (NOS) expression play a role in neuropathic pain in a rat model. METHODS: Neuropathic pain was produced by resecting two branches of the sciatic nerve. N-nitro-L-arginine methyl ester (L-NAME) (a nonselective NOS inhibitor), or 7-nitroindazole (7-NI) (a neuronal NOS (nNOS) inhibitor), or aminoguanidine (AG) (an inducible NOS (iNOS) inhibitor) were administered locally for 2, 7, or 14 days via osmotic pumps. Behavioral tests for pain were conducted after nerve injury using mechanical and thermal stimuli applied to the hind paws. We used immunohistochemical methods to provide evidence for endothelial NOS (eNOS), nNOS, and iNOS expression. RESULTS: Following nerve injury, significant mechanical allodynia and thermal hyperalgesia were observed in rats treated with AG or 7-NI. In contrast, when L-NAME, a known potent inhibitor of eNOS was applied locally, no significant mechanical allodynia or thermal hyperalgesia was observed. No dependency on the route or duration of NOS inhibitor administration was noted. Increased immunoreactivities of the eNOS and nNOS isoforms were intense and discrete at 48 hour following nerve injury, unlike sham exposed intact nerves. In 14 day stumps, iNOS staining was observed in the endoneurium and perineurium. eNOS immunoreactivity at 2 days after nerve injury was not observed in L-NAME treated rats. At 14 days after nerve injury, iNOS immunoreactivity was rarely observed in AG and L-NAME treated rats. CONCLUSIONS: Our results indicate that an early eNOS expression plays a critical role in the development of neuropathic pain.
